Activity Expired

2007 Psychopharmacology Update - Online CME Program
Developmental Aspects of Psychopharmacological Treatment in Children, Adolescents, and Adults

Sponsored by eAACAP, Chaired by Robert Hendren, D.O.
Supported through an educational grant from Eli Lilly and Company.

PROGRAM GOALS AND OVERVIEW
The goal of the 2007 Psychopharmacology Update Online Program is to provide an update regarding the safety and efficacy of psychotropic medications comparing and contrasting children, adolescent, and adults. Practitioners are exposed to expert opinions and the most current data on developmental differences in the conditions being treated as well as the overall risks and benefits of the treatments.

Learning Objectives
At the conclusion of this online CME activity, the participant should be able to:

• Discuss the evidence-based research on ADHD psychopharmacological treatments.
• Outline general guidelines for the use of sleep medications in pediatric insomnia.
• Describe how SSRIs work in both the maturing and matured brain, and discuss the recent studies involving the use of SSRIs.
• Identify symptom/behavior differences between mania as it presents in children, adolescents, and adults, and discuss the current evidence-based information about differences in bipolar medication treatment.
• Describe medication strategies for Obsessive Compulsive Disorder.
• Discuss the appropriate monitoring techniques to detect drug-related endocrine complications.
• Employ treatment strategies for Tourette's Disorders and co-occurring conditions.

Target Audience
This educational activity is designed for child and adolescent psychiatrists, pediatricians, family practice physicians, and other healthcare professionals with a special interest in the psychopharmacological treatment of children and adolescents.

Original Release Date: September 5, 2007
Review Date: September 4, 2007
Expiration Date: September 30, 2008

Continuing Medical Education Credit
This course is one in a continuing medical education series under the direction of the American Academy of Child and Adolescent Psychiatry's Institutes Subcommittee and eAACAP. The American Academy of Child and Adolescent Psychiatry is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

The American Academy of Child and Adolescent Psychiatry designates the educational activity for a maximum of 14 hours of category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.